Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis.
Natsuki IshidaTakahiro MiyazuSatoshi TamuraShinya TaniMihoko YamadeMoriya IwaizumiYasushi HamayaSatoshi OsawaTakahisa FurutaKen SugimotoPublished in: Digestive diseases and sciences (2021)
Tofacitinib is a promising therapeutic agent for the induction and maintenance therapy in UC. Baseline UCEIS may predict its therapeutic effects.